FDG PET hot spots predict better prognosis in spinal surgery patients

August 14, 2013

Doctors can now tell how effective a surgery for degenerative cervical myelopathy will be based on how much FDG is taken up by the cervical spinal cord, according to research published online August 5 in the Journal of Nuclear Medicine.

Frank W. Floeth, MD, from the department of neurosurgery at University of Dusseldorf in Dusseldorf, Germany, and colleagues evaluated patients with degenerative cervical spine stenosis for variations in glucose metabolism in areas of the cervical spine with F-18 FDG PET. Researchers found that hypermetabolism in this area prior to surgery was a direct indicator of better surgical outcomes.